New medicine to prevent cytomegalovirus disease in stem cell transplant patients

View source ↗

Summary

EMA announces a new medicine approved to prevent cytomegalovirus disease in stem cell transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Disease
• Cytomegalovirus Infection in Stem Cell Transplant Recipients